Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Chao Jiang , Zhao Zixu Added: 6 months ago
AHA Scientific Sessions 2025 – Dr Chao Jiang and Dr Zhao Zixu (Beijing Anzhen Hospital, CN) discuss the findings from the DARE-AF (NCT06433479) randomized clinical trial, investigating whether dapagliflozin reduces atrial fibrillation burden following catheter ablation in patients without diabetes or heart failure.This single-center, open-label trial enrolled 200 patients with persistent atrial… View more
Added: 10 months ago Source:  Radcliffe Cardiology
The long-term utility of beta-blockers following an uncomplicated myocardial infarction (MI) remains a subject of clinical debate. New secondary results from the AβYSS trial (Assessment of β-blocker interruption one Year after an uncomplicated myocardial infarction on Safety and Symptomatic cardiac events requiring hospitalization) reveal that interrupting this therapy leads to sustained… View more
Author(s): Emma Sandgren , Dominik Linz , Added: 3 months ago
Prof Dominik Linz (Maastricht University Medical Centre, Maastricht, NL) moderates a discussion with Dr Emma Sandgren (Karolinska Institutet Danderyd Hospital, Stockholm, SE) and Dr Martin Manninger-Wünscher (Medical University of Graz, Graz, AU) on the clinical implementation and future potential of photoplethysmography (PPG) in atrial fibrillation management.The panel explores PPG's role as a… View more